These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8385830)

  • 41. Cytomegalovirus infection, fulminant hepatitis, and liver transplantation: the sides of the triangle.
    Samuel D; Dussaix E
    Liver Transpl Surg; 1997 Sep; 3(5):547-51. PubMed ID: 9346800
    [No Abstract]   [Full Text] [Related]  

  • 42. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
    Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV
    Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
    Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients].
    Moreno J; Montero JL; Gavilán F; Costán G; Herrero C; Cárdenas M; Sánchez-Guijo P; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 1999 Oct; 17(8):382-5. PubMed ID: 10563084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.
    Paya CV; Wilson JA; Espy MJ; Sia IG; DeBernardi MJ; Smith TF; Patel R; Jenkins G; Harmsen WS; Vanness DJ; Wiesner RH
    J Infect Dis; 2002 Apr; 185(7):854-60. PubMed ID: 11920308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved survival with cytomegalovirus infection after intestinal transplantation in children.
    Bueno J; Green M; Reyes J; Jabbour N; Kocoshis S; Yunis E; Todo S; Starzl TE
    Transplant Proc; 1996 Oct; 28(5):2770-1. PubMed ID: 8908050
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug therapy of intractable virus diseases].
    Goto H
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1685-8. PubMed ID: 1964166
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytomegalovirus syndrome post-renal transplantation. Treatment with cytosine arabinoside.
    Fine RN; Malekzadeh M; Grushkin CM; Wright HT
    Calif Med; 1973 Mar; 118(3):46-9. PubMed ID: 4347632
    [No Abstract]   [Full Text] [Related]  

  • 52. Intrapancreatic abscess formation in pancreatic transplant recipients with positive cytomegalovirus serology: a rare cause of graft loss which may be prevented.
    Bäckman L; Brattström C; Reinholt FP; Andersson J; Tydén G
    Transplant Proc; 1990 Apr; 22(2):639-40. PubMed ID: 2158167
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluating sirolimus-based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation.
    Arasaratnam RJ
    Clin Transplant; 2015 Sep; 29(9):723. PubMed ID: 26265556
    [No Abstract]   [Full Text] [Related]  

  • 54. Cytomegalovirus-Associated Glomerulonephritis in a Kidney Transplant Recipient.
    Neto MM; Costa RS; Frezza G; Garcia TM; Nardin MEP; Romao EA
    Prog Transplant; 2018 Dec; 28(4):398-399. PubMed ID: 30244653
    [No Abstract]   [Full Text] [Related]  

  • 55. [Possible inhibitors of experimental viral replication against cytomegalovirus. Results and prospectives].
    Landini MP; Baldassarri B; Ripalti A
    G Ital Chemioter; 1985; 32(1):119-26. PubMed ID: 3007252
    [No Abstract]   [Full Text] [Related]  

  • 56. Acyclovir prophylaxis for cytomegalovirus in liver transplant recipients.
    Singh N; Yu VL
    J Infect Dis; 1994 Jun; 169(6):1406-7. PubMed ID: 8195627
    [No Abstract]   [Full Text] [Related]  

  • 57. Does acute rejection correlate with infection in liver transplantation?
    Höckerstedt K; Butrón T; Salmela K; Ahonen J; Eklund B; Isoniemi H; Holmberg C; Kyllönen L; Lautenschlager I
    Transplant Proc; 1992 Feb; 24(1):296-7. PubMed ID: 1311475
    [No Abstract]   [Full Text] [Related]  

  • 58. Prophylaxis for cytomegalovirus disease after liver transplant.
    Singh N; Yu VL
    Clin Infect Dis; 1996 Jun; 22(6):1133-5. PubMed ID: 8783744
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytomegalovirus infection and treatment with ganciclovir. A conference. San Francisco, California, 21-22 May 1987. Proceedings.
    Rev Infect Dis; 1988; 10 Suppl 3():S457-572. PubMed ID: 2847281
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytomegalovirus endometritis after liver transplantation.
    Sayage L; Gunby R; Gonwa T; Husberg B; Goldstein R; Klintmalm G
    Transplantation; 1990 Apr; 49(4):815-7. PubMed ID: 2158160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.